This document discusses Prajith V PharmD's background and contact information. It then provides information on the Doctor of Pharmacy program in India, job opportunities for PharmD graduates, and areas of practice for clinical pharmacists. The Federation of Indian Pharmacists Organization has urged the government to revise rules to allow pharmacists to pursue higher studies like the PharmD. The rest of the document discusses pharmacovigilance in India, including the objectives of the national pharmacovigilance program launched in 2010 to monitor adverse drug reactions.

1. Prajith.V PharmD @Sri Ramakrishna Institute
of Paramedical Sciences
Prajithkanna@gmail.com

2.  PCI President Dr B Suresh who brought Doctor of Pharmacy
Program to India
 About 62% of licensed pharmacists work in community
pharmacies and 23% work in hospitals
 About 71% of Pharmacy Technician jobs are in pharmacies,
grocery stores, department stores, or mass retailers.

3.  Pharmacy council of India started the programme in
the year 2008 with a good intention to improve the
pharmacy services in the Indian healthcare system
and to increase the dignity of the profession. But,
from the beginning a group of people have been
raising allegations about the way the programme
was introduced and the way it is disturbing the
smooth running of the course putting the students
into a quandary.
 http://www.acharya.ac.in/pharmd.html

4.  A Pharm D graduate could find jobs mostly related
to the clinical force of India. With gradual
amendments being made in the health care
industry, the Pharm D graduate could play an
active role in heading the Hospital Pharmacy
Setting (Hospital Setting / Hospital Pharmacy.
 Also with a large number of Pharmaceutical
companies opting for clinical trials the industry is
heading towards a business worth 1.4 billion by
way of clinical trials.

5.  Hospital Pharmacy
 Community Pharmacy
 Clinical Pharmacy
 Clinical Pharmacokinetics
 Clinical trial safety

16. The Federation of Indian Pharmacists Organization (FIPO) has urged
the Department of Personnel & Training (DoPT), government of
India to revise the Rule 51 of the Central Civil Services Leave Rules
(CCS) in order to facilitate the pharmacists in the central
government health services to pursue higher studies in pharmacy,
especially the three-year Pharm D (PB) programme

17.  Hospital Pharmacy
 Community Pharmacy
 Clinical Pharmacy
 Clinical Pharmacokinetics
 Clinical trial safety

18.  Pharmacovigilance
 Pharmaco-economics
 Adverse Drug Reactions (ADRs)
 Clinical Research Organizations
 Biostatistics and Research Methodology

19.  Clinical Toxicology
 Clinical Research,
Pharmacoepidemiology
 Pharmacotherapeutic Drug Monitoring
 Clinical Pharmacokinetics
 Pharmacoeconomics
 Drug Safety
 Forensic Pharmacy
 Forensic Psychology

20.  Foreign Pharmacy Graduate Examination
Committee (FPGEC)

21. Surveillance Programmes In India

22. Introduction why Pharmacovigilance
Aim of Pharmacovigilance
Pharmacovigilance: Future Challenges, Need &
issues
Outcome of successful Program in
Pharmacovigilance
Summery & Conclusion

23. BY V . PRAJITH

25.  Pharmacovigilance Programme of India launched on July 14,
2010 is currently capturing ADR data in Indian population in a
systematic way in coordination with the IPC. The main
objective of the Programme is to monitor ADRs in Indian
population.
 Safety Monitoring of Medicinal Products
 Pharmacovigilance (PV or PhV), also known as Drug Safety

26.  All medicines have risks as well as benefits. The aim of
Pharmacovigilance 1 is to protect public health by
identifying, evaluating, managing and minimizing safety
Issues to ensure that the overall benefits of medicines
outweigh the risks.
 Patient safety is a fundamental principle
 Apply computerized statistical tool s to facilitate the
evaluation of safety information through, for example, the
identification of unexpected adverse events that are being
reported on a disproportionate basis (safety signals)
 The science of Pharmacovigilance is continuously evolving
and is actively involved in working with industry, regulators,
healthcare professionals and patients to enhance
methodologies in this area

27.  Drug Technical Advisory Board (DTAB) set up Vigilance
Cells
 Forensic Pharmacy and Forensic Psychology
 Adverse Drug Reactions (ADRs)
 Clinical Trial Safety

28.  In this regard, IPC which acts as the national coordination
centre (NCC) for Pharmacovigilance Program of India (PvPI)
already had a series of strategic meetings with the Centre
over the last few months.
 Since 2011, around 1,10,000 adverse drug reactions have
been reported from across the country. However, this was
after the government made it mandatory for hospitals to
have a pharmacovigilance cell. Still, officials say, there are
only few hospitals across the country operating with a
proper cell.
 Currently, there are only 150 hospitals across the country
which have pharmacovigilance cell, the official cell.
However, the health ministry and the drug regulator are
making efforts to ramp up such cells.

29. Haemovigilance Meterio-Vigilance
Bio-Vigilance

31. prajithkanna@gmail.com